Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Retained Earnings: 2020-2025

Historic Retained Earnings for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$377.8 million.

  • Insight Molecular Diagnostics' Retained Earnings fell 19.17% to -$377.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$377.8 million, marking a year-over-year decrease of 19.17%. This contributed to the annual value of -$350.5 million for FY2024, which is 20.93% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Retained Earnings stood at -$377.8 million for Q3 2025, which was down 2.94% from -$367.0 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Retained Earnings ranged from a high of -$127.6 million in Q1 2021 and a low of -$377.8 million during Q3 2025.
  • Over the past 3 years, Insight Molecular Diagnostics' median Retained Earnings value was -$310.3 million (recorded in 2024), while the average stood at -$320.0 million.
  • Data for Insight Molecular Diagnostics' Retained Earnings shows a maximum YoY crashed of 55.26% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Retained Earnings stood at -$187.8 million in 2021, then crashed by 38.82% to -$260.7 million in 2022, then fell by 11.20% to -$289.9 million in 2023, then decreased by 20.93% to -$350.5 million in 2024, then dropped by 19.17% to -$377.8 million in 2025.
  • Its Retained Earnings stands at -$377.8 million for Q3 2025, versus -$367.0 million for Q2 2025 and -$357.2 million for Q1 2025.